SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-190714
Filing Date
2004-11-09
Accepted
2004-11-09 11:35:57
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 d10q.htm 10-Q 418665
2 EMPLOYEE CONFIDENTIALITY, INVENTION ASSIGNMENT dex104.htm EX-10.4 26219
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8582
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8584
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4265
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4268
  Complete submission text file 0001193125-04-190714.txt   472775
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 041128014
SIC: 2834 Pharmaceutical Preparations